BNP Paribas Asset Management
KURA icon

BNP Paribas Asset Management’s Kura Oncology KURA Stock Holding History

BNP Paribas Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.8K Buy
1,326
+563
+74% +$4.84K ﹤0.01% 2196
2025
Q4 		$8K Buy
+763
New +$8.01K ﹤0.01% 2216
2025
Q1 		– Sell
-694,387
Closed -$6.05M – 898
2024
Q4 		$6.05M Buy
+694,387
New +$9.99M 0.02% 523

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BNP Paribas Asset Management's KURA Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Kura Oncology (KURA) stake by 74% in Q1 2026, buying an estimated $4.84K and bringing the position to 1,326 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2196.

BNP Paribas Asset Management first reported a position in KURA in Q4 2024 and has held it in 3 quarters since. The position peaked at $6.05M in Q4 2024. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • BNP Paribas Asset Management held 1,326 shares of Kura Oncology worth $10.8K as of Q1 2026.
  • BNP Paribas Asset Management bought 563 Kura Oncology shares in Q1 2026, an estimated $4.84K.
  • Kura Oncology made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #2196 holding.
  • BNP Paribas Asset Management first reported a position in Kura Oncology in Q4 2024 and has held it in 3 quarters since.
  • BNP Paribas Asset Management's Kura Oncology position peaked at $6.05M in Q4 2024.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.